Patent intelligence · AT
AT E245157
3,9-DIAZABICYCLO-(3.3.1)-NONANYLDERIVATE, VERFAHREN UND INTERMEDIATE FÜR IHRE DARSTELLUNG UND SIE ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN
3,9-DIAZABICYCLO-(3.3.1)-NONANYLDERIVATE, VERFAHREN UND INTERMEDIATE FÜR IHRE DARSTELLUNG UND SIE ENTHALTENDE PHARMAZEUTISCHE …
Patent details — AT E245157
- Jurisdiction
- AT
- Status
- expired
- Grant date
- Aug 15, 2003
- Expiration
- Aug 10, 2023
- Applicant
- BEECHAM GROUP PLC [GB]
- CPC classes
- A61K 31/ 495 A I, A61K31/495, A61P 1/ 08 A I, A61P 25/ 00 A I
Quick answer
AT E245157 (3,9-DIAZABICYCLO-(3.3.1)-NONANYLDERIVATE, VERFAHREN UND INTERMEDIATE FÜR IHRE DARSTELLUNG UND SIE ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN) is held by BEECHAM GROUP PLC [GB]. Status: expired. Granted Aug 15, 2003. Expires Aug 10, 2023 (0 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- BEECHAM GROUP PLC [GB]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 31/ 495 A I, A61K31/495, A61P 1/ 08 A I, A61P 25/ 00 A I, A61P 25/ 04 A I, A61P 43/ 00 A I
More from BEECHAM GROUP PLC [GB]
Related pharmaceutical patents in our USPTO index.
-
SA 92120308
تركيبة للاستخدام الموضعي topical composition
expired -
AT E269330
CHEMISCHE VERBINDUNGEN
expired -
EP 1425277
HARNSTOFF-DERIVATE ALS VANILLOID-REZEPTOR-ANTAGONISTEN FÜR DIE SCHMERZBEHANDLUNG
expired -
SA 91110341
مستحضر موضعي لعلاج العدوى بفيروس الحلا (القوباء) Herpesvirus
expired -
HU P0302480
PYRIDINONE DERIVATIVES FOR TREATMENT OF ATHEROSCLEROSIS, PROCESS FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
expired -
HK 1004528
Dentifrice compositions
expired -
HU P0204410
PYRIMIDINE-4-ONE DERIVATIVES, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE
expired
Frequently asked questions
What is US patent E245157?
AT E245157 (3,9-DIAZABICYCLO-(3.3.1)-NONANYLDERIVATE, VERFAHREN UND INTERMEDIATE FÜR IHRE DARSTELLUNG UND SIE ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN) is held by BEECHAM GROUP PLC [GB]. Status: expired. Granted Aug 15, 2003. Expires Aug 10, 2023 (0 years remaining) — relevant for patent-cliff and LOE planning.
Who owns AT E245157?
BEECHAM GROUP PLC [GB] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 25 pharmaceutical patents for this assignee.
When does AT E245157 expire?
Our index shows an expiration date of Aug 10, 2023 (0 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.